Literature DB >> 8309476

Differences in the biochemical properties of esterolytic antibodies correlate with structural diversity.

R Zemel1, D G Schindler, D S Tawfik, Z Eshhar, B S Green.   

Abstract

A prerequisite to the design and engineering of catalytic antibodies is the knowledge of their structure and in particular which residues are involved in binding and catalysis. We compared the structure and catalytic properties of a series of six monoclonal antibodies which were all raised against a p-nitrophenyl (PNP) phosphonate and which catalyze the hydrolysis of p-nitrophenyl esters. Three of the antibodies (Group I) have similar light and heavy chain variable regions. The other three antibodies have similar VL regions of which two (Group II) have VH regions from the MOPC21 gene family and the remaining one (Group III) a VH from the MC101 gene family making a total of three different groups based on their V region sequences. The structural division into groups is paralleled by the differences in binding constants to hapten analogs, substrate specificity and the susceptibility of the catalytic activity of the antibodies to chemical modification of tryptophan and arginine residues. The relative binding of a transition state analog to the binding of substrate is much higher for the Group I antibodies than for the other groups. Only the Group I antibodies can catalyze the hydrolysis of a carbonate substrate. However all of the antibodies lose catalytic activity upon specific tyrosine modification which highlights the importance of tyrosine in the active site of the antibodies. Thus, antibodies raised against a single hapten can give antibodies with different structures, and correspondingly different specificities and catalytic properties.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8309476     DOI: 10.1016/0161-5890(94)90085-x

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  5 in total

1.  Binding specificity of hydrolytic catalytic antibody: lessons from the diverse immune system.

Authors:  Y Wada; M Ono
Journal:  J Protein Chem       Date:  1999-02

Review 2.  Catalytic antibodies: a critical assessment.

Authors:  D S Tawfik; Z Eshhar; B S Green
Journal:  Mol Biotechnol       Date:  1994-02       Impact factor: 2.695

3.  Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.

Authors:  N L Tout; J S Lam
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

4.  Unexpectedly high occurrence of catalytic antibodies in MRL/lpr and SJL mice immunized with a transition-state analog: is there a linkage to autoimmunity?

Authors:  D S Tawfik; R Chap; B S Green; M Sela; Z Eshhar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

5.  Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.

Authors:  J B Charbonnier; E Carpenter; B Gigant; B Golinelli-Pimpaneau; Z Eshhar; B S Green; M Knossow
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.